The three finalists for the $1 million Magee Prize — the highlight of this week’s Magee-Womens Research Summit and the largest monetary award ever given for women’s health research — will present their projects Tuesday for summit participants and find out that evening who is the winner.

It has been a year since it was first announced, and now the summit is set to go Tuesday and Wednesday at the David L. Lawrence Convention Center, Downtown. The event organized by the Magee-Womens Research Institute is packed with talks on the latest research on women’s health across the life span as well as sessions open to the public on Tuesday.

On the agenda are speakers from around the world and discussions on topics addressing reproductive biology, healthy aging, factors behind infant and maternal deaths and the prevention of chronic diseases.

Each of the three Magee Prize proposals for innovative women’s health research represents the work of an international team of experts; two of the proposals include researchers from the University of Pittsburgh.

Advertise with us

Yaacov Barak of Pitt built a team to pursue a proposed project on the placental origin of congenital heart defects. Years ago, he had found that mouse embryos with a particular mutated gene had fatal defects in both the placenta and the heart.

But, he said, the world was not ready to accept the idea at the time. He decided to go after the Magee award, in light of more recent research that found that human babies with congenital heart defects were more likely also to have had a defective placenta.

Basic research can develop stronger mouse models to investigate the placenta-heart connection, Mr. Barak said.

“We have good models, but we can make great models, to demonstrate how this happens in the mouse and, by inference, human babies,” he said.

The goal is finding the problem early enough to prevent the heart defect or to correct it early, before the emotional and financial cost of later surgery, Mr. Barak said, noting that new techniques and knowledge of the human genome will move this research forward.

Advertise with us

“The tools are there, but nothing has been done to address this problem. … We’re trying to move this from fantasy to reality,” he said.

On the team are placenta expert Myriam Hemberger of the University of Calgary and heart expert Henry Sucov of the University of Southern California.

Another team’s proposal seeks to help infertile couples. Two Pitt researchers, Alexander Yatsenko and Kyle Orwig, would build on their work to identify and repair faulty genes responsible for problems some men and women have in producing viable germline cells — sperm or eggs.

“Everybody in our team is interested in the causes of infertility,” Mr. Orwig said.

There has been little help for men and women who are not able to produce sperm or an egg, he said, estimating that includes about 1.3 million Americans. Some kind of genetic defect is suspected in many of those cases.

Advertise with us

Collaborating on the team are Katsuhiko Hayashi of Kyushu University in Japan and Amander Clark of the University of California Los Angeles, experts in creating germ cells from any cell in the body.

The team proposes to use skin cells of an infertile patient, reprogram them into germ cell “precursors” and then use the latest gene editing techniques to repair the mutations that cause infertility. Then the team will switch to mouse models to prove that this process can produce healthy babies.

Dr. Yatsenko, a human geneticist, has a strategy for figuring out what gene is causing the infertility, Mr. Orwig said. If Dr. Yatsenko suspects a genetic basis for the infertility, he’ll take a blood sample and sequence the individual’s genome and identify what can be thousands of mutations. Those are filtered with the results of similar testing done in three or four family members, including both infertile and fertile individuals, Mr. Orwig explained.

Dr. Yatsenko can narrow the search down to one or two of the suspected mutations, he said. He added that he himself can produce mouse models with those same mutations. After that, other animal species would be used to replicate results, he said.

“Ultimately we want to work in human cells — show we can accurately identify and repair the mutation and actively create germ cells,” he said. It’s parallel research, he explained, adding that “both models have strengths and weaknesses.”

Advertise with us

The third finalist is a group of long-time collaborators led by Hilary Gammill of the University of Washington that built a proposal using research on fetal cells and associations with pre-eclampsia and cardiovascular disease. Also on the team are Carl Hubel of Pitt and Annetine Staff of the University of Oslo.

Mr. Hubel and Dr. Staff have been following hundreds of women after their pregnancy to determine the risk factors contributing to cardiovascular disease. The project would combine the two groups of women, creating a larger study group, and enable the scientists to look into the fetal cells and their gene expression patterns to gauge their effect on each mother’s heart health later in life.

The opening keynote speaker at the summit Tuesday morning is biotech pioneer Leroy Hood, who is known for building the scientific instruments that led to the mapping of the human genome and automating DNA sequencing and precision medicine.

The Magee Prize is funded by the Richard King Mellon Foundation. It will be awarded by the dinner’s keynote speaker, Lara Logan, CBS News chief foreign affairs correspondent and an advocate for women’s health issues worldwide.

Ms. Logan said she has spoken about her own experience with breast cancer to draw donations for research and she knows scientists often struggle to get money for their work.

Advertise with us

She’s impressed with the Magee Prize and its focus on women’s health.

“I love the fact they’re going out of the box to fund things that can’t get funding,” she said.

Her personal health issue, she said, came from injuries suffered in a brutal gang rape in Cairo during the Arab Spring in 2011. She recalled the team of doctors at Sibley Memorial Hospital in Washington, D.C., who coordinated her complex care when she first landed back in the U.S. after the attack. It included several abdominal surgeries.

“I had never thought about the long-term consequences of health,” Ms. Logan said.

But she found that though she was healed, she developed a painful condition called interstitial cystitis, also known as painful bladder syndrome. It’s not well understood and it took some time before she was diagnosed.

Advertise with us

“There’s significant pain, crippling at times,” she said.

Specialists then told her there were lots of things to try as a treatment, she said, “but they have no idea what actually works.”

Born in South Africa, she said she is proud that when Nelson Mandela became president in 1994, he launched free medical care to pregnant women and children age 5 and under.

“It was such a moving thing, from this man I respected so much,” Ms. Logan said. “You can’t live in Africa and see the burden women carry and forget that.”

Women’s health issues may differ around the world, she said, but medical advances often emerge out of research done in the United States.

Advertise with us

“What happens in the U.S. ripples across the world. The effects are truly profound,” Ms. Logan said.

More information: mageesummit.org

Jill Daly: jdaly@post-gazette.com, 412-263-1596.